Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial
Open Access
- 15 July 2025
- journal article
- research article
- Published by Elsevier in Annals of Intensive Care
- Vol. 15 (1) , 98-10
Abstract
No abstract availableKeywords
Funding Information
- Københavns Universitet
This publication has 35 references indexed in Scilit:
- Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trialPharmacological Reports, 2021
- Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialIntensive Care Medicine, 2021
- Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe HypoxemiaJAMA, 2021
- High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysisDiabetes Research and Clinical Practice, 2021
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19JAMA, 2020
- Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deteriorationDiabetes Research and Clinical Practice, 2020
- Hyperglycaemia on admission to hospital and COVID-19Diabetologia, 2020
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020
- Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infectionClinical Immunology, 2018
- Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trialDiabetologia, 2011